Skip to main content
| News

NextImmune to benefit from Venture Kick financing

27.06.2022

The startup accelerator Venture Kick is supporting NextImmune with financing in the amount of 150,000 Swiss francs. The spin-off from the University of Basel is working on the development of selective immunosuppressive drugs. The fresh capital injection will facilitate preclinical development work at NextImmune.

Dr. med. Rajesh Jayachandran, Chief Scientific Officer and co-founder of NextImmune (img: NextImmune)

This year, Venture Kick is planning to support projects initiated by startups that open up access to the global markets for scientific organizations in Switzerland to the tune of 6.1 million Swiss francs overall, further details of which can be found in a press release issued by the startup accelerator based in Schlieren in the canton of Zurich. NextImmune can now look forward to banking a total of 150,000 Swiss francs from this pot. The spin-off from the University of Basel will put this financing towards developing a new generation of immunosuppressive therapies.

The Basel-based startup is working on the development of selective immunosuppressive drugs that protect against autoimmune diseases and transplant rejection without also compromising the immune response the human body requires to defend against infections and cancers. The financing should now enable NextImmune to carry out further preclinical development, the press release states. “The financial support, business insights, access to a smart pool of diversely talented individuals together with the overall experience gathered from our Venture kick journey will be instrumental for the follow-up fundraising activities of NextImmune”, explains Rajesh Jayachandran, Chief Scientific Officer and co-founder of NextImmune, in the press release.

BaseLaunch also supports NextImmune

NextImmune’s therapeutic approach is intended to help patients suffering from immunological or autoimmune diseases. The startup is also expecting interest from biotech and pharmaceutical companies that could market such an approach under a licensing agreement, Venture Kick writes in the press release. NextImmune is also supported by BaseLaunch. The biotech accelerator from the investment and innovation promotion agency Basel Area Business & Innovation included the startup in its portfolio in June of last year.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Basel Area achieves milestone with settling of LifeMine
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Basel Area achieves milestone with settling of LifeMine

Life sciences company LifeMine Therapeutics from the USA has established its European headquarters in the Basel Area. With this, Basel...

Read More
Space Pharmaceuticals establishes presence in Basel
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Space Pharmaceuticals establishes presence in Basel

Space Pharmaceuticals AG is strengthening the life sciences cluster in the Basel Area. At its research lab, the cheminformatics company...

Read More
Basel Area Business & Innovation, Innovation, Life Sciences / biotech

NextImmune to benefit from Venture Kick financing

The startup accelerator Venture Kick is supporting NextImmune with financing in the amount of 150,000 Swiss francs. The spin-off from...

Read More
Basel Area Business & Innovation, Innovation, Medtech, Switzerland Innovation Park

OECD impressed by the canton of Jura’s innovation system

The OECD has examined the innovation systems in place in rural areas of its member states, including the canton of...

Read More
Basel Area Business & Innovation, ICT, Innovation, Invest

ti&m opens branch in Basel

ti&m now has an office in Basel. With this action, the company specializing in digitization, security and innovation projects is...

Read More
What can artificial intelligence do for health?
Basel Area Business & Innovation, Digital Health, Innovation, Life Sciences / biotech, Medtech

What can artificial intelligence do for health?

Algorithms help diagnose and treat diseases, discover new drugs and personalize prevention. Thus, the potential of artificial intelligence has been...

Read More
1 2 3 56

Do you have a question? We'd like to hear from you.